Stenting may benefit patients with renal artery stenosis who have historically been excluded from modern clinical trials.
An SBP target of about 120-140 rather than below 140 mm Hg may be more beneficial.
Patients are more likely to receive a kidney transplant and less likely to die than patients with end-stage renal disease from other causes.
Second review shows value in CKD with suspected ACS, limited by variable sensitivity/specificity.
Increased long-term mortality risk for patients with, but not those without, chronic kidney disease.
CRP is an independent risk factor the development of CKD.
Severe CKD raised the risk of in-hospital death after coronary artery bypass grafting surgery.
Mean estimated glomerular filtration rate decreases by 0.57 mL/min/1.73 m2 annually with each 1-year increase in age at donation.
Major perioperative complications and death are more likely in patients with chronic kidney disease stages 3-5.
Heavy and binge drinking found to significantly decrease the likelihood of renal dysfunction.
It is associated with better long-term survival and reduced risk of revascularization and myocardial infarction compared with PCI.
Low hemoglobin levels increase the risk of death, sepsis, and cerebrovascular accidents following cardiac surgery.
A history of nephrolithiasis was associated with a nearly 2-fold increased odds of chronic kidney disease in women.
In a study, hypertension, obesity, and higher triglycerides predicted development of chronic kidney disease 30 years later.
Serum bicarbonate could potentially be used to identify patients at elevated risk for chronic kidney disease.
Hepatitis C virus infection increases CKD patients' likelihood of progressing to end-stage renal disease by 32%.
Researchers find no association between sodium excretion and decline in eGFR.
Renal function decline is not accelerated, however.
Korean study also revealed an inverse association between serum homocysteine levels and renal function.
Heart failure, myocardial infarction, or stroke also increase the risk of death prior to ESRD.
If renal replacement therapy planning were started only when patients reached CKD stage 5, many patients would not be adequately prepared, researchers said.
Dr. Moe spoke about the importance of nephrology research and how a prize competition can facilitate the process.
A nearly 5-fold higher risk of Clostridium difficile infection observed in patients with end-stage renal disease requiring dialysis.
Study reveals a more rapid decline in annual eGFR among individuals whose parents had cardiovascular disease.
Many patients still insist that I need to check and manage their cholesterol.
Lower risk of overall mortality, renal replacement therapy seen with more walking.
Cholesterol-lowering therapy is indicated in CKD patients to prevent cardiovascular risk.
Increased maximal carotid artery plaque is associated with a greater likelihood of occlusive coronary disease in patients with and without CKD.
Confirmation of creatinine-based eGFR should be performed in select circumstances using, where appropriate, either measured GFR or cystatin C.
In a 5-year follow-up study, 27 of 28 patients treated with adrenocorticotropic hormone had complete or partial remission.